The pharmaceutical c... 申请号：JP2015122510 专利类型：发明授权 公开（公告）日：
状态：寻求转化 转让价格：面议
PROBLEM TO BE SOLVED : To provide W/O type cream pharmaceutical preparations containing a particular drug, such as crotamiton, the W/O type cream pharmaceutical preparations inhibiting the reductio...
The pharmaceutical c... 申请号：JP2016181739 专利类型：发明授权 公开（公告）日：2016-09-16
状态：寻求转化 转让价格：面议
The purpose of the present invention is to provide : a pharmaceutical composition that comprises the pyridylaminoacetic acid compound of the present invention, said pyridylaminoacetic acid compound ...
The pharmaceutical c... 申请号：JP2018564968 专利类型：发明申请 公开（公告）日：
状态：寻求转化 转让价格：面议
Provided are the use of lipids bearing fatty acids with an odd number of carbon atoms as pharmaceuticals or nutritional supplement. In particular, such lipids are used in the treatment and/or prevent...
The pharmaceutical c... 申请号：JP2018540766 专利类型：发明申请 公开（公告）日：
状态：寻求转化 转让价格：面议
The present invention relates to a paclitaxel pharmaceutic composition and a pharmaceutic preparation, a preparation process therefor and use thereof. The paclitaxel composition comprises paclitaxel ...
The pharmaceutical c... 申请号：JP2015219845 专利类型：发明授权 公开（公告）日：
状态：寻求转化 转让价格：面议
An object of the present invention is to find which of an enormous number of pyridylaminoacetic acid compounds has a particularly excellent intraocular pressure lowering effect and may be used as a th...
The patient' s healt... 申请号：JP2015505006 专利类型：发明授权 公开（公告）日：
状态：寻求转化 转让价格：面议
The invention concerns a medical device comprising a device for the measurement of a health parameter of a patient, a device for capturing a fingerprint identifying the patient, a device for communi...
The oxetane -3 - ylo... 申请号：JP2018554102 专利类型：发明申请 公开（公告）日：
状态：寻求转化 转让价格：面议
The invention relates to antibacterial compounds of formula (I), wherein U1 represents N or CH, U2 represents N or CH, U3 represents N or CH, it being understood that at most two of U1, U2, U3 c...
The oxalate formulat... 申请号：JP2018537629 专利类型：发明申请 公开（公告）日：
状态：寻求转化 转让价格：面议
The present invention relates to pharmaceutically acceptable formulations comprising oxalate salts of Teneligliptin and solvates thereof. Also provided are combinations with biguanides and use of said...
The outer medulla of... 申请号：JP2018562650 专利类型：发明申请 公开（公告）日：
状态：寻求转化 转让价格：面议
Provided is a pharmaceutically acceptable salt as a renal outer medullary potassium channel (ROMK) inhibitor, specifically an L-tartrate and a crystal form I and crystal form II thereof. The pharmace...
